A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Chimerix Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 600,000 shares of CMRX stock, worth $582,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600,000
Previous 400,000 50.0%
Holding current value
$582,000
Previous $424,000 24.53%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.05 $174,000 - $210,000
200,000 Added 50.0%
600,000 $528,000
Q2 2023

Aug 14, 2023

BUY
$1.1 - $1.54 $440,000 - $616,000
400,000 New
400,000 $484,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $670,000 - $2.67 Million
500,000 New
500,000 $1.04 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.